Schizophrenia Spectrum Disorder

2

Review clinical trials related to Schizophrenia Spectrum Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial

This study aims to compare the efficacy of classical Metacognitive Training (MCT) and personalized Metacognitive Training (P-MCT) for individuals with psychosis. MCT is a psychoeducational program derived from cognitive-behavioral therapy (CBT) that targets cognitive biases associated with psychotic symptoms. The goal is to assess which intervention is more effective to improve the overall functioning of individuals with psychosis. The study will use machine learning to personalize the treatment approach and evaluate its impact on clinical symptoms, cognitive functions, and quality of life.

Participants needed: 51
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: University Hospital, Strasbourg, FranceUpdated: Aug 20, 2026Locations: 1
Eligibility criteria

Adults, 18 - 65 years of age. [+5]

Having received MCT in the previous year. [+7]

Status: Recruiting

Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders

The purpose of this study is to determine if repetitive transcranial magnetic stimulation (rTMS) applied to angular gyrus (AG) will improve negative symptoms and/or other psychosis symptoms in schizophrenia spectrum disorders (SSD) patients compared with prefrontal cortex (PFC) or sham.

Participants needed: 20
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: The University of Texas Health Science Center, HoustonUpdated: Mar 24, 2026Locations: 1
Eligibility criteria

Ability to give written informed consent [+4]

Persons with a first-degree relative with inherited epilepsy, seizure disorder,... [+10]